no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acute transverse myelitis following SARS-CoV-2 infection
|
Jauregui-Larrañaga, C. |
|
|
36 |
7 |
p. 572-574 |
article |
2 |
Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine
|
Crespo Burillo, J.A. |
|
|
36 |
7 |
p. 571-572 |
article |
3 |
Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community
|
Vázquez-Costa, J.F. |
|
|
36 |
7 |
p. 504-513 |
article |
4 |
A new protocol reduces median door-to-needle time to the benchmark of 30 minutes in acute stroke treatment
|
Iglesias Mohedano, A.M. |
|
|
36 |
7 |
p. 487-494 |
article |
5 |
Association between cerebral folate deficiency and hereditary spastic paraplegia
|
Duarte, S. |
|
|
36 |
7 |
p. 550-552 |
article |
6 |
Bell’s palsy following COVID-19 vaccination: a case report
|
Gómez de Terreros Caro, G. |
|
|
36 |
7 |
p. 567-568 |
article |
7 |
Burned-out hippocampus syndrome: myth or reality? A case report
|
Freire Carlier, I.D. |
|
|
36 |
7 |
p. 558-561 |
article |
8 |
Cavernous sinus syndrome secondary to invasive aspergilosis with carotid involvement in a HIV pacient
|
Saldaña Inda, I. |
|
|
36 |
7 |
p. 552-554 |
article |
9 |
COVID-19 related strokes: Pandora's Box may open as the p(c)lot thickens!
|
Magoon, R. |
|
|
36 |
7 |
p. 562-563 |
article |
10 |
Incidence and clinical characteristics of Guillain-Barré syndrome in Osona (Barcelona, Spain), 2003-2016
|
Aragonès, J.M. |
|
|
36 |
7 |
p. 525-530 |
article |
11 |
Liquorice-associated bilateral non-arteritic anterior ischaemic optic neuropathy
|
Oribio-Quinto, C. |
|
|
36 |
7 |
p. 554-556 |
article |
12 |
Manual therapy in adults with tension-type headache: A systematic review
|
Cumplido-Trasmonte, C. |
|
|
36 |
7 |
p. 537-547 |
article |
13 |
Myasthenia gravis and systemic lupus erythematosus: presentation of 5 cases and PubMed review
|
Jiménez-Alonso, J. |
|
|
36 |
7 |
p. 556-557 |
article |
14 |
Neuropsychological rehabilitation program for patients with post-COVID-19 syndrome: a clinical experience
|
García-Molina, A. |
|
|
36 |
7 |
p. 565-566 |
article |
15 |
Parsonage-Turner syndrome post-infection by SARS-CoV-2: a case report
|
Alvarado, M. |
|
|
36 |
7 |
p. 568-571 |
article |
16 |
Posterior reversible encephalopathy associated with pembrolizumab
|
Lambea-Gil, Á. |
|
|
36 |
7 |
p. 548-550 |
article |
17 |
Recurrent Miller Fisher syndrome: Case report
|
Peral Quirós, A. |
|
|
36 |
7 |
p. 561-562 |
article |
18 |
Reply
|
Barrios-López, J.M. |
|
|
36 |
7 |
p. 563-564 |
article |
19 |
Reply
|
Trejo-Gabriel-Galán, José María |
|
|
36 |
7 |
p. 564-565 |
article |
20 |
SARS-CoV-2 infection: possible underdiagnosis of cerebral venous sinus thrombosis
|
Almarcha-Menargues, M.L. |
|
|
36 |
7 |
p. 575-576 |
article |
21 |
The influence of interferon β-1b on gut microbiota composition in patients with multiple sclerosis
|
Castillo-Álvarez, F. |
|
|
36 |
7 |
p. 495-503 |
article |
22 |
Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: regional analysis of the impact of COVID-19
|
Tejada Meza, H. |
|
|
36 |
7 |
p. 531-536 |
article |
23 |
Transcultural adaptation and validation of the Spanish-language version of ACTIVLIM in adults with inherited myopathies using the Rasch model
|
Pagola, I. |
|
|
36 |
7 |
p. 514-524 |
article |